The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome
Status:
Completed
Trial end date:
2017-12-30
Target enrollment:
Participant gender:
Summary
This study will test the hypothesis that reducing the release of free fatty acids (FFA) from
fat cells will restore insulin-mediated, endothelium-dependent vasodilation in people with
the metabolic syndrome.